Scan Positivity and Management Change per Patient Group
| Group | Positive | Intermodality change | Intramodality change | Other (imaging/short-interval follow-up) | Total management change per group |
|---|---|---|---|---|---|
| A | 18 (90%) | 4 (RP to RT [1], RT to RP [1], RT to RT with field change [1], RP to hormones [1]) | 1 (RP with lymph node dissection to RP alone) | 1 (spine MRI) | 30.0% |
| B | 3 (14.3%) | 6 (RT to surveillance [4], RT to hormones [2]) | 1 (RT to RT with field change) | 2 (liver MRI [1], short-interval repeat PET/CT [1]) | 42.9% |
| C | 6 (75%) | 6 (salvage RP/focal therapy of prostate to hormones/chemotherapy [3], hormones to template biopsy for consideration of salvage RP/focal therapy [2], salvage RP/focal therapy of prostate to surveillance [1]) | 0 | 0 | 75.0% |
| Total | 27 (55.1%) | 16 | 2 | 3 | 42.9% |
RP = radical prostatectomy; RT = radiotherapy.